ArticleClinical and molecular hepatology2017

Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function.

Hyun Phil Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.